ACME UNITED CORP - 10-Q Summary (Q1 2008)
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for ACME UNITED CORPORATION for the period ended March 31, 2008. The company manufactures cutting devices, measuring instruments, and safety products for school, office, home, and industrial use. Operations are reported in three segments: United States (including Asia), Canada, and Europe.
Key Financial Metrics
| Metric | Q1 2008 | Q1 2007 |
|---|---|---|
| Net Sales | $14,269,000 | $12,241,000 |
| Gross Profit | $5,986,000 | $5,334,000 |
| Gross Margin | 41.9% | 43.6% |
| Operating Income | $1,068,000 | $1,176,000 |
| Net Income | $753,000 | $650,000 |
| Diluted EPS | $0.21 | $0.17 |
| Cash & Equivalents | $4,815,000 | $3,386,000 |
| Working Capital | $31,786,000 | $29,378,000 |
| Total Debt | $12,670,000 | $10,150,000 |
| Current Ratio | 5.66 | 4.46 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 17% year-over-year (13% at constant currency), driven primarily by a 17% increase in the U.S. segment due to higher sales of pencil sharpeners, medications, and paper trimmers.
- Margin Compression: Gross margin decreased 1.7% to 41.9%, attributed to a higher proportion of lower-margin medication sales in the U.S. segment.
- Operating Income: Despite revenue growth, operating income declined 9% to $1.068 million. The U.S. segment operating income fell 16% due to product mix and increased SG&A expenses, partially offset by gains in Canada and Europe.
- Cash Flow: Net cash used by operating activities was $1.491 million, compared to $319,000 used in the prior year. This was driven by a $965,000 increase in inventory and a $995,000 decrease in accrued liabilities.
- Debt Levels: Total debt increased by approximately $2.52 million to fund inventory buildup and stock repurchases.
Outlook, Risks, and Management Commentary
- Seasonality: Management notes that sales are traditionally stronger in the second and third quarters due to the back-to-school market.
- Liquidity: The company maintains a revolving credit facility of $15 million with $2.33 million available as of March 31, 2008. Management believes cash flow and available credit are sufficient for the next 12 months.
- Stock Repurchases: The company repurchased 57,200 shares in Q1 2008 under a program allowing up to 150,000 shares. 117,600 shares remain available for purchase under current programs.
- Risks: Key risks include economic strength in operating regions, consumer spending habits, competition, and currency fluctuations. No material legal proceedings are currently expected to impact financial position.
Investor Verification Checklist
- Verify the sustainability of the 17% U.S. sales growth given the seasonal nature of the back-to-school market.
- Monitor the impact of the lower-margin medication product mix on future gross margins.
- Review the $12.67 million debt level against the $15 million credit facility limit and the June 30, 2009 maturity date.
- Assess the cash burn from operations ($1.49M used) and its relation to inventory buildup strategies.
- Confirm the effectiveness of cost controls as SG&A expenses rose to 34.5% of sales.